KATO MEDICAL ApS: Financial statements 2024
CVR: 30703391
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
KATO MEDICAL ApS (CVR 30703391) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -16,158 and a net result of DKK -202,605 compared with DKK 468,896 the year before. Equity in the 2024 report amounted to DKK 1,438,074. The solvency ratio was 95.9%.
- Gross Profit
- DKK -16,158
- Profit/Loss
- DKK -202,605
- Equity
- DKK 1,438,074
- Total Assets
- DKK 1,498,844
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -16K | -203K | 1.4M | - |
| 2023 | - | -15K | 469K | 1.9M | - |
| 2022 | - | -30K | 73K | 1.8M | - |
| 2021 | - | -15K | 177K | 2M | - |
| 2020 | - | -17K | 419K | 2.1M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
KATO MEDICAL ApS has published its annual report for 2023. Gross profit came to DKK -15,303, and the net result was DKK 468,896.
About KATO MEDICAL ApS
KATO MEDICAL ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2007. The company is registered under the industry Speciallægers aktiviteter. The management consists of Karsten Thomsen and Tove Birkebæk Thomsen. The company's owners include Karsten Thomsen, Tove Birkebæk Thomsen and Frederik Ferløv Thomsen. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -35,921 and a net result of DKK -687,381 compared with DKK -202,605 the year before. Equity in the 2025 report amounted to DKK 750,693.
